Safety profile of baricitinib for the treatment of rheumatoid arthritis up to 9.3 years: an updated integrated safety analysis
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Langue: | English |
| Publié: |
Journal of Rheumatology
2022
|